Skip to main content
Clinical Trials/NCT04789460
NCT04789460
Completed
Not Applicable

Relationship Between Potential Predictors and Mortality in COVID-19 Patients in Turkey: A New Prognostic Model

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey1 site in 1 country816 target enrollmentMarch 5, 2021
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Enrollment
816
Locations
1
Primary Endpoint
mortality rate
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

In this study, the investigators planned to examine the laboratory characteristics of patients hospitalized with the diagnosis of Covid-19 and to investigate their relationship with mortality.

Detailed Description

SARS-CoV-2 infection is effective in many countries and has caused pandemics. It is observed that it affects patients in a wide spectrum in terms of their clinical features worldwide. It is known that age, gender, and comorbidity play an important role in the course of the disease. Although mortality rates vary from country to country, there is no clear information due to the fact that the pandemic has not yet ended. In this study, the investigators planned to examine the laboratory characteristics of patients hospitalized with the diagnosis of Covid-19 and to investigate their relationship with mortality in Istanbul city which is the most affected by the pandemic in Turkey

Registry
clinicaltrials.gov
Start Date
March 5, 2021
End Date
March 28, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients who are 18 years of age and older, positive for SARS-CoV-2 PCR test and / or Covid-19 disease findings on CT will be included in the study.

Exclusion Criteria

  • Patients with negative SARS-CoV-2 PCR test, pneumonia on CT but not given Covid-19 treatment by not considering Covid-19 by their doctor will not be included.

Outcomes

Primary Outcomes

mortality rate

Time Frame: up to 30 days

up to 30 days after discharge

Secondary Outcomes

  • need for intensive care unit rate(up to 30 days)
  • length stay in hospital(up to 30 days)

Study Sites (1)

Loading locations...

Similar Trials